The United Kingdom’s National Institute for Health and Care Excellence (NICE) has issued a final appraisal determination (FAD) that recommends Bavencio (avelumab) for treating adults with metastatic Merkel cell carcinoma (mMCC). Avelumab is recommended for routine NHS use in England, Wales, and Northern Ireland for treating metastatic mMCC in adults, only if they have had one or…